Renovo (RenovoRx Nasdaq: RNXT), is a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform. Oncologist is an international peer-reviewed...
RenovoRx (RNXT) is a life sciences company at the forefront of developing targeted oncology therapies aimed at addressing unmet medical needs in cancer treatment....
Hey everyone! If you're exploring new investment opportunities for late October, consider taking a look at NurExone (TSXV: NRX, OTCQB: NRXBF, FRA: J90). The...
Once you review this piece, consider buying or watch listing this unique biopharmaceutical company. The company's focus is therapy and, eventually, possibly, a cure...
NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company developing exosome-based therapies for the multi-billion dollar regenerative medicine market....